168 related articles for article (PubMed ID: 23721130)
1. Thrombin-activatable fibrinolysis inhibitor protects against acute lung injury by inhibiting the complement system.
Naito M; Taguchi O; Kobayashi T; Takagi T; D'Alessandro-Gabazza CN; Matsushima Y; Boveda-Ruiz D; Gil-Bernabe P; Matsumoto T; Chelakkot-Govindalayathil AL; Toda M; Yasukawa A; Hataji O; Morser J; Takei Y; Gabazza EC
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):646-53. PubMed ID: 23721130
[TBL] [Abstract][Full Text] [Related]
2. Role of thrombin-activatable fibrinolysis inhibitor in allergic bronchial asthma.
Fujiwara A; Taguchi O; Takagi T; D'Alessandro-Gabazza CN; Boveda-Ruiz D; Toda M; Yasukawa A; Matsushima Y; Miyake Y; Kobayashi H; Kobayashi T; Gil-Bernabe P; Naito M; Yoshida M; Morser J; Takei Y; Gabazza EC
Lung; 2012 Apr; 190(2):189-98. PubMed ID: 22037793
[TBL] [Abstract][Full Text] [Related]
3. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
[TBL] [Abstract][Full Text] [Related]
4. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
Bouma BN; Mosnier LO
Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302
[TBL] [Abstract][Full Text] [Related]
5. Absence of thrombin-activatable fibrinolysis inhibitor protects against sepsis-induced liver injury in mice.
Renckens R; Roelofs JJ; ter Horst SA; van 't Veer C; Havik SR; Florquin S; Wagenaar GT; Meijers JC; van der Poll T
J Immunol; 2005 Nov; 175(10):6764-71. PubMed ID: 16272333
[TBL] [Abstract][Full Text] [Related]
6. Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency.
Bruno NE; Yano Y; Takei Y; Qin L; Suzuki T; Morser J; D'Alessandro-Gabazza CN; Mizoguchi A; Suzuki K; Taguchi O; Gabazza EC; Sumida Y
Thromb Haemost; 2008 Jul; 100(1):90-100. PubMed ID: 18612543
[TBL] [Abstract][Full Text] [Related]
7. Role of CD69 in acute lung injury.
Ishizaki S; Kasuya Y; Kuroda F; Tanaka K; Tsuyusaki J; Yamauchi K; Matsunaga H; Iwamura C; Nakayama T; Tatsumi K
Life Sci; 2012 May; 90(17-18):657-65. PubMed ID: 22483694
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension is ameliorated in mice deficient in thrombin-activatable fibrinolysis inhibitor.
Qin L; D'Alessandro-Gabazza CN; Aoki S; Gil-Bernabe P; Yano Y; Takagi T; Boveda-Ruiz D; Ramirez Marmol AY; San Martin Montenegro VT; Toda M; Miyake Y; Taguchi O; Takei Y; Morser J; Gabazza EC
J Thromb Haemost; 2010 Apr; 8(4):808-16. PubMed ID: 20088932
[TBL] [Abstract][Full Text] [Related]
9. Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury.
Bosmann M; Grailer JJ; Ruemmler R; Russkamp NF; Zetoune FS; Sarma JV; Standiford TJ; Ward PA
FASEB J; 2013 Dec; 27(12):5010-21. PubMed ID: 23982144
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide-induced lung injury: role of P2X7 receptor.
Monção-Ribeiro LC; Cagido VR; Lima-Murad G; Santana PT; Riva DR; Borojevic R; Zin WA; Cavalcante MC; Riça I; Brando-Lima AC; Takiya CM; Faffe DS; Coutinho-Silva R
Respir Physiol Neurobiol; 2011 Dec; 179(2-3):314-25. PubMed ID: 21982752
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin protects against lipopolysaccharide-induced acute lung injury in mice.
Li XJ; Liu DP; Chen HL; Pan XH; Kong QY; Pang QF
Int Immunopharmacol; 2012 Feb; 12(2):460-4. PubMed ID: 22251871
[TBL] [Abstract][Full Text] [Related]
12. Taraxacum officinale protects against lipopolysaccharide-induced acute lung injury in mice.
Liu L; Xiong H; Ping J; Ju Y; Zhang X
J Ethnopharmacol; 2010 Jul; 130(2):392-7. PubMed ID: 20510343
[TBL] [Abstract][Full Text] [Related]
13. Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation.
Myles T; Nishimura T; Yun TH; Nagashima M; Morser J; Patterson AJ; Pearl RG; Leung LL
J Biol Chem; 2003 Dec; 278(51):51059-67. PubMed ID: 14525995
[TBL] [Abstract][Full Text] [Related]
14. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
Mosnier LO; Elisen MG; Bouma BN; Meijers JC
Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
[TBL] [Abstract][Full Text] [Related]
15. [Roles of peroxiredoxin 6 in the regulation of oxidative stress to lipopolysaccharide-induced acute lung injury].
Yang D; Bai CX; Wang X; An XJ; Tong L; Bi J
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Sep; 34(9):679-83. PubMed ID: 22177494
[TBL] [Abstract][Full Text] [Related]
16. The role of protein S in the activation of thrombin activatable fibrinolysis inhibitor (TAFI) and regulation of fibrinolysis.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Oct; 86(4):1040-6. PubMed ID: 11686322
[TBL] [Abstract][Full Text] [Related]
17. Generation of C5a in the absence of C3: a new complement activation pathway.
Huber-Lang M; Sarma JV; Zetoune FS; Rittirsch D; Neff TA; McGuire SR; Lambris JD; Warner RL; Flierl MA; Hoesel LM; Gebhard F; Younger JG; Drouin SM; Wetsel RA; Ward PA
Nat Med; 2006 Jun; 12(6):682-7. PubMed ID: 16715088
[TBL] [Abstract][Full Text] [Related]
18. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
Boffa MB; Koschinsky ML
Clin Biochem; 2007 Apr; 40(7):431-42. PubMed ID: 17331488
[TBL] [Abstract][Full Text] [Related]
19. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
Thromb Haemost; 2004 Mar; 91(3):480-6. PubMed ID: 14983223
[TBL] [Abstract][Full Text] [Related]
20. Thrombin-activatable fibrinolysis inhibitor influences disease severity in humans and mice with pneumococcal meningitis.
Mook-Kanamori BB; Valls Serón M; Geldhoff M; Havik SR; van der Ende A; Baas F; van der Poll T; Meijers JC; P Morgan B; Brouwer MC; van de Beek D
J Thromb Haemost; 2015 Nov; 13(11):2076-86. PubMed ID: 26340319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
